A detailed history of Abundance Wealth Counselors transactions in Abb Vie Inc. stock. As of the latest transaction made, Abundance Wealth Counselors holds 16,115 shares of ABBV stock, worth $2.9 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
16,115
Previous 16,545 2.6%
Holding current value
$2.9 Million
Previous $2.84 Million 12.12%
% of portfolio
0.66%
Previous 1.31%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$163.84 - $199.33 $70,451 - $85,711
-430 Reduced 2.6%
16,115 $3.18 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $198,905 - $232,276
-1,285 Reduced 7.21%
16,545 $2.84 Million
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $25,890 - $29,500
162 Added 0.92%
17,830 $3.25 Million
Q4 2023

Jan 17, 2024

BUY
$137.6 - $154.97 $34,400 - $38,742
250 Added 1.44%
17,668 $2.74 Million
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $46,756 - $54,127
-350 Reduced 1.97%
17,418 $2.6 Million
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $221,424 - $275,547
-1,671 Reduced 8.6%
17,768 $2.39 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $197,971 - $227,993
-1,369 Reduced 6.58%
19,439 $3.1 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $355,733 - $426,617
2,572 Added 14.1%
20,808 $3.36 Million
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $229,871 - $275,675
-1,662 Reduced 8.35%
18,236 $2.95 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $51,402 - $58,955
383 Added 1.96%
19,898 $2.67 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $73,076 - $92,903
-531 Reduced 2.65%
19,515 $2.99 Million
Q1 2022

Apr 28, 2022

BUY
$131.98 - $163.75 $174,873 - $216,968
1,325 Added 7.08%
20,046 $3.25 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $87,877 - $111,190
818 Added 4.57%
18,721 $2.54 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $47,667 - $54,109
448 Added 2.57%
17,903 $1.93 Million
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $205 Million - $228 Million
-1,948,676 Reduced 99.11%
17,455 $1.97 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $206 Million - $229 Million
1,954,842 Added 17316.34%
1,966,131 $17,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $1.06 Million - $1.17 Million
10,352 Added 1104.8%
11,289 $1.22 Million
Q1 2021

May 05, 2021

SELL
$102.3 - $112.62 $912,413 - $1 Million
-8,919 Reduced 90.49%
937 $60,000
Q4 2020

Jan 27, 2021

BUY
$80.49 - $108.67 $128,542 - $173,545
1,597 Added 19.34%
9,856 $1.06 Million
Q3 2020

Nov 04, 2020

BUY
$85.91 - $100.83 $144,500 - $169,596
1,682 Added 25.57%
8,259 $723,000
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $482,554 - $645,729
6,577 New
6,577 $646,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Abundance Wealth Counselors Portfolio

Follow Abundance Wealth Counselors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abundance Wealth Counselors, based on Form 13F filings with the SEC.

News

Stay updated on Abundance Wealth Counselors with notifications on news.